Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: Richard Huth who wrote (722)	9/2/1998 1:18:00 AM
From: Rocketman	Respond to of 3202

Richard, Sorry if my tone came across as getting on your case. That wasn't my intent. I am however annoyed with the market reaction to INCY and I think it carried over a bit much towards you. I am also a bit annoyed with INCY's management's confusing communications with the markets - they haven't helped matters much. I think they could have done a better job of explaining the Hexagen deal and the set up of the new company and how it would effect INCY General's financials and avoided much of the confusion. Face it, you got me going on a good rant and I was feeling kind of wired this morning and voila, a volatile response. I agree with you that what the market does is reality, the rest is just opinion. And, give the AFFX announcement today and the further dump in INCY, you had it called right so far. Cheaper prices for INCY were to be had if you were waiting for a buy in. IMO it sure is about time for some good news from this company! They not only have hurting shareholders, but 2/3 of the employees were hired in the last two years and will have options that are now underwater, so I'm sure they have some employees who are bumming out now too. Hope they are now more motivated to fix things quick! Rman

To: Richard Huth who wrote (722)	9/10/1998 1:43:00 AM
From: George Sepetjian	Read Replies (1) \| Respond to of 3202

INCY is down 54% YTD. I agree with your comments about the 'market' being Right. This stock has essentially blown-up this year. But ask yourself what biotech or software company,with the exception of Microsoft, hasn't? It just so happens INCY is a hybrid of both industries and currently is being punished for it. The so-called smartmoney started abandoning INCY simply because they could actually quantify their earnings & have probably projected that they've contracted with all the major players in the near-term & that they don't have any catalyst to create an earnings surprise to merit the sky-hi p/e it once had. Patience will be rewarded. Consider it a 5 year CD. Now if I only had the guts to short Amazon.com.........